Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy.
Guy A MacGowanJulie SamuelAdam McDiarmidOscar Gonzalez-FernandezGareth ParryPublished in: Clinical transplantation (2024)
There is no significant increased mortality or morbidity using a CMV surveillance and preemptive therapy protocol. The effect of donor age on seroconversion of mismatches requires further validation.